Tacrolimus induced diabetic ketoacidosis in nephrotic syndrome.

about

Tacrolimus combined with low-dose corticosteroids is an effective and safe therapeutic option for refractory IgA nephropathy.

P2860

Q37205233-01DFB149-471D-403C-815D-655E3BDC159F

P2860

Tacrolimus induced diabetic ketoacidosis in nephrotic syndrome.

Item

http://www.wikidata.org/entity/Q46755996

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Tacrolimus induced diabetic ketoacidosis in nephrotic syndrome.

@en

Tacrolimus induced diabetic ketoacidosis in nephrotic syndrome.

@nl

type

Item

label

Tacrolimus induced diabetic ketoacidosis in nephrotic syndrome.

@en

Tacrolimus induced diabetic ketoacidosis in nephrotic syndrome.

@nl

prefLabel

Tacrolimus induced diabetic ketoacidosis in nephrotic syndrome.

@en

Tacrolimus induced diabetic ketoacidosis in nephrotic syndrome.

@nl

P1476

Tacrolimus induced diabetic ketoacidosis in nephrotic syndrome.

@en

P2093

Anjan Kumar Das

http://www.w3.org/2001/XMLSchema#string

Madhumita Nandi

http://www.w3.org/2001/XMLSchema#string

Rakesh Mondal

http://www.w3.org/2001/XMLSchema#string

Sumantra Sarkar

http://www.w3.org/2001/XMLSchema#string

P2860

European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and Adolescents

Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells.

Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.

Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.

Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.

P2888

s12098-012-0797-6

P304

596-597

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12098-012-0797-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225095126

http://www.w3.org/2001/XMLSchema#string

P698

22660906

http://www.w3.org/2001/XMLSchema#string

Tacrolimus induced diabetic ketoacidosis in nephrotic syndrome.

about

P2860

P2860

Tacrolimus induced diabetic ketoacidosis in nephrotic syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698